EBCI focuses on brain disease education, outreach, and awareness to this patient community and their families...worldwide.

National Cancer Institute (NCI) researchers are conducting a study of patients with IDH-mutated gliomas.

Each May the EndBrainCancer Initiative, in Partnership with Novocure, has presented the HOPE award to brain cancer patients who deeply inspire us with their courage and story.

If you have been diagnosed with rGBM (first recurrence only), would you like to participate in a PAID short interview?

Join our virtual event on May 19th featuring Dr. Thomas Lechner.

The new EBCI app is the fastest way to learn of new treatment options, trials, events, webinars, research updates, and so much more!

Children's Brain Tumor Foundation has developed a series of Support Group Events in the month of March to address the needs of various patients, family members, and caregivers.

"When Randy Cordova was first diagnosed with a glioblastoma brain tumor, the news, he says, was earth-shaking. He and his wife Maura cried, prayed and committed to beating it. ...

This webinar is open to anyone interested in attending. We encourage Oncology Nurses, Navigation Nurses, Genetic Counselors, Oncologists, Patient Advocates / Caregivers and Patients to attend. May 12, 2023

This webinar will explore evidence-supported lifestyle and dietary therapies to promoted physical and mental wellbeing. Feb. 23, 2023

Read about this NEW Clinical Trial and review the eligibility guidelines! "The Ivy Brain Tumor Center at Barrow Neurological Institute is conducting a Phase 1/2 study of sonodynamic therapy (SDT) in patients with recurrent glioblastoma (rGBM).

Scientists at Brigham and Women’s Hospital are harnessing a new way to turn cancer cells into potent, anti-cancer agents. Khalid Shah and his team have developed a new cancer-killing vaccine that can be used to treat existing tumors and prevent recurrences.